TRAX — First Tracks Biotherapeutics Inc stock price, charts and financials

QT90First Tracks Biotherapeutics Inc

First Tracks Biotherapeutics Inc (NASDAQ: TRAX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
46.01
-0.15-0.33%
OverviewShort InterestFilings
TRAXQT90First Tracks Biotherapeutics Inc·NASDAQ
46.01-0.33%
TA
Loading chart...
Screen all →
OCUL+2.26%$8.59STOK+7.14%$31.67TSHA+7.27%$6.20AUPH+2.47%$14.93MESO+2.28%$14.80URGN+3.45%$39.92TYRA+1.53%$32.53IOVA+0.93%$4.36
Snapshot
Index-P/E-EPS (ttm)-Insider Own-Shs Outstand34.89MPerf Week9.83%
Market Cap1.61BForward P/E-EPS next Y-Insider Trans-Shs Float31.05MPerf Month139.17%
Enterprise Value1.31BPEG-EPS next Q-Inst Own-Short Float15.37%Perf Quarter106.26%
Income-166.00MP/S0.00EPS this Y-Inst Trans-Short Ratio7.32Perf Half Y-
Sales0.00P/B5.61EPS next Y-ROA-33.62%Short Interest4.77MPerf YTD125.06%
Book/sh8.23P/C5.16EPS next 5Y-ROE-30.10%52W High47.84 -3.83%Perf Year-
Cash/sh8.94P/FCF-EPS past 3/5Y-ROIC-40.43%52W Low14.67 213.59%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y-Gross Margin0.00%Volatility9.58% 13.08%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-Oper. Margin0.00%ATR (14)4.02Perf 10Y-
Dividend Ex-Date-Quick Ratio8.74Sales Y/Y TTM-Profit Margin0.00%RSI (14)73.32Recom2.00
Dividend Gr. 3/5Y-Current Ratio8.74EPS Q/Q-SMA2025.31%Beta3.18Target Price50.29
Payout0.00%Debt/Eq0.04Sales Q/Q-SMA5084.10%Rel Volume0.36Prev Close46.16
Employees104LT Debt/Eq0.04EarningsAug 07SMA20099.06%Avg Volume716.76KPrice46.01
IPO DateApr 20, 2026Option/ShortNo / YesEPS/Sales Surpr.-Net Debt/EBITDA2.40Volume259,634Change-0.33%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-28-26ReiteratedWedbush$30 → $60
Jul-28-26ReiteratedWells Fargo$30 → $55
Jul-21-26ReiteratedBarclays$40 → $48
Jul-10-26ReiteratedH.C. Wainwright$30 → $44
Jun-08-26InitiatedWells FargoOverweight$30
May-04-26InitiatedPiper SandlerOverweight$54
Apr-28-26InitiatedH.CBuy$30
Apr-24-26InitiatedLeerinkOutperform$46
Apr-21-26InitiatedUBSBuy$45
Latest News
Company

First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
Total Revenue
000
Cost of Goods Sold Incl. D&A1401520
Gross Profit-140-1520
Selling, General and Administrative Excl. Other392921
Research and Development14015298
Other Operating Expense-140-152-1
Operating Income-179-181-118
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)131712
Net Income Before Taxes-166-164-106
Income Taxes
000
Consolidated Net Income-166-164-106
Net Income From Continuing Operations-166-164-106
Net Income-166-164-106
EPS (Recurring)0.000.00-3.05
EPS (Basic, Before Extraordinaries)0.000.00-3.05
EPS (Diluted)0.000.00-3.05
EBITDA-178-179-116
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding0035
Market Capitalization
———
Operating Lease Expense
———
Insider Trading Volume
$52.65$42.10$31.55$21.00$10.45● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.